Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| 0.10M CSO in Anhydrous Acetonitrile | 0.10M CSO in Anhydrous Acetonitrile is a popular reagent used in various biomedical laboratories. Notably, it plays a crucial role in the research of synthesis of drugs, especially targeting cardiovascular diseases and cancer. |  |
| 0.5% DiI Encapsulated DOTAP Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. |  |
| 0.5% DiI Encapsulated DOTMA Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% DiO Encapsulated DOTAP Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% DiO Encapsulated DOTMA Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DC-Chol:DOPE (1:2) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DC-Chol:DOPE (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DDAB:Chol (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DDAB:DOPE (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DDAB Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DOTAP:Chol (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DOTAP:Chol:DOPE (10:75:5) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DOTAP:DOPE (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DOTMA:Chol (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated DOTMA:DOPE (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% NBD-DOPE Encapsulated GL-67:DOPE (1:2) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DC-Chol:DOPE (1:2) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DC-Chol:DOPE (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DDAB:Chol (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DDAB:DOPE (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DDAB Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DOTAP:Chol (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DOTAP:Chol:DOPE (10:75:5) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DOTAP:DOPE (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DOTMA:Chol (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated DOTMA:DOPE (50:50) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 0.5% Rhod-PE Encapsulated GL-67:DOPE (1:2) Liposomes | Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy. Uses: Cancer research; target delivery. Group: Cationic liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| 1,2,3,4,6-Penta-O-(3,4,5-tri-O-benzylgalloyl)-b-D-glucopyranose | 1,2,3,4,6-Penta-O-(3,4,5-tri-O-benzylgalloyl)-b-D-glucopyranose is an innovative and synthetic analogue of gallic acid, showcasing outstanding antioxidant attributes accompanied by powerful anticancer characteristics. As it is primarily deployed in the development of therapeutic stratagems targeting multifarious oncological conditions, such as mammary and oral malignancies, it becomes an indispensable tool in cancer research. Synonyms: 1,2,3,4,6-Penta-O-(3,4,5-tri-O-benzylgalloyl)-b-D-glucopyranose; [(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4,5-tris(phenylmethoxy)benzoyl]oxy]oxan-2-yl]methyl 3,4,5-tris(phenylmethoxy)benzoate; (2S, 3R, 4S, 5R, 6R) -6- ( ( (3, 4, 5-Tris (benzyloxy) benzoyl) oxy) methyl) tetrahydro-2H-pyran-2, 3, 4, 5-tetrayl tetrakis(3,4,5-tris(benzyloxy)benzoate); DXBOPZWOODFFKH-JKUAIIEZSA-N; beta-d-glucopyranose pentakis[3,4,5-tris(phenylmethoxy)-benzoate]; Pentakis[3,4,5-tris(phenylmethoxy)benzoate] beta-D-Glucopyranose; 1,2,3,4,6-Penta-O-(3,4,5-tri-O-benzylgalloyl)- beta -D-glucopyranose; 1,2,3,4,6-Penta-O-(3,4,5-tri-O-benzylgalloyl)-?-D-glucopyranose; 1,2,3,4,6-Penta-O-(3,4,5-tri-O-benzylgalloyl)-beta-D-glucopyranose; 1,2,3,4,6-Pentakis-O-[3,4,5-tris(benzyloxy)benzoyl]-beta-D-glucopyranose. CAS No. 122625-60-9. Molecular formula: C146H122O26. Mole weight: 2292.52. | |
| 1,2,3,4,6-Penta-O-acetyl-5-thio-D-galactopyranose | 1,2,3,4,6-Penta-O-acetyl-5-thio-D-galactopyranose, a frequently employed chemical compound in carbohydrate and glycoconjugate synthesis, has demonstrated inhibitory impacts on assorted enzymes associated with diseases, inclusive of cancer and viral infections. Its employment as a therapeutic agent has displayed potential for curbing metastasis in cancer and tackling viral infections by truncating viral replication. Further research may enable a more comprehensive understanding of its therapeutic potential. | |
| 1,2,3,4,6-Penta-O-acetyl-5-thio-D-galactose | 1,2,3,4,6-Penta-O-acetyl-5-thio-D-galactose, a biochemical compound, boasts an enigmatic complexity that has piqued the interest of researchers. Its potential to be employed in the development of treatments to mitigate critical illnesses, like cancer or as an anti-inflammatory agent, evokes curiosity. In essence, it presents itself as an intriguing venture in the pursuit of new medical treatments. Molecular formula: C16H22O10S. Mole weight: 406.41. | |
| 1,2,3,4,6-Penta-O-acetyl-a-D-talopyranose | 1,2,3,4,6-Penta-O-acetyl-a-D-talopyranose is a compound commonly used in the synthesis of carbohydrate-based materials and as a reagent in biochemical research. It has been studied for its potential in the treatment of cancer and diabetes. Synonyms: SCHEMBL7152018; tetraacetate1111. CAS No. 19186-39-1. Molecular formula: C16H22O11. Mole weight: 390.34. | |
| 1,2,3,4,6-Penta-O-acetyl-b-D-galactopyranose | 1,2,3,4,6-Penta-O-acetyl-b-D-galactopyranose is an indispensable compound assuming a prominent position in drug research and development for an array of ailments such as cancer and bacterial infections. Synonyms: b-D-Galactose pentaacetate. CAS No. 4163-60-4. Molecular formula: C16H22O11. Mole weight: 390.34. | |
| 1,2,3,4,6-Penta-O-acetyl-b-L-glucopyranose | 1,2,3,4,6-Penta-O-acetyl-b-L-glucopyranose is a valuable compound widely used in the biomedical industry. It is mainly utilized as a precursor in the synthesis of various drugs targeting diseases like diabetes, Alzheimer's, and cancer. With its unique chemical structure and excellent reactivity, this compound plays a crucial role in the development of novel therapeutics and furthering medical research. Synonyms: beta-L-glucose pentaacetate; [(2S,3S,4R,5S,6R)-3,4,5,6-tetraacetyloxyoxan-2-yl]methyl acetate; (2R,3S,4R,5S,6S)-6-(Acetoxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate; B-L-GLUCOSE PENTAACETATE; -L-Glucose pentaacetate; SCHEMBL23266161; P-1656. CAS No. 66966-07-2. Molecular formula: C16H22O11. Mole weight: 390.34. | |
| 1,2,3,4,6-Penta-O-acetyl-D-mannopyranose | 1,2,3,4,6-Penta-O-acetyl-D-mannopyranose is a derivative of mannopyranose used mainly in the manufacture of certain antibiotics like Erythromycin and Clarithromycin. It also plays a significant role in research fields pertaining to Glycobiology and cancer therapy. Synonyms: D-Mannose pentaacetate. CAS No. 25941-03-1. Molecular formula: C16H22O11. Mole weight: 390.34. | |
| 1,2,3,4,6-Penta-O-benzoyl-a-D-mannopyranose | 1,2,3,4,6-Penta-O-benzoyl-a-D-mannopyranose, a derivative of mannose, plays a pivotal role as an intermediate compound for synthesizing glycosylated drugs in the biomedical industry. Due to its distinctive attributes, it serves as an indispensable reagent in the development of treatments for various diseases such as cancer, diabetes, and HIV. Its chemical structure exhibits perplexing intricacies, rendering it a critical component in the realm of pharmaceutical research and development, and extensively aids in the progressive advancement of medicine. Synonyms: (2R,3S,4S,5R,6R)-6-((Benzoyloxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrabenzoate; 1,2,3,4,6-Penta-O-benzoyl-alpha-D-mannopyranose; 1,2,3,4,6-Penta-O-benzoylhexopyranose #; SCHEMBL7642894.alpha.-d-Mannose pentabenzoate; JJNMLNFZFGSWQR-LAWAEFJSSA-N; MFCD12407879; Penta-O-benzoyl-alpha-D-mannopyranose; AKOS015919019; CS-0098163; 1,2,3,4,6-Penta-O-benzoyl--D-mannopyranose; D96136; 1,2,3,4,6-Penta-O-benzoyl-|A-D-mannopyranose; [(2R,3R,4S,5S,6R)-3,4,5,6-tetrabenzoyloxyoxan-2-yl]methyl benzoate. CAS No. 41569-33-9. Molecular formula: C41H32O11. Mole weight: 700.7. | |
| 1,2,3,4,6-Penta-O-pivaloyl-a-D-mannopyranose | 1,2,3,4,6-Penta-O-pivaloyl-a-D-mannopyranose, a derivative of carbohydrates, has found a significant place in the biomedical industry owing to its multifunctional properties. As a shielding agent for carbohydrates, it enables drug delivery and formulation, and displays potential therapeutic applications in various diseases such as cancer, diabetes, and microbial infections. Its unique chemical structure and versatility make it a promising candidate for advanced research and development. Molecular formula: C31H52O11. Mole weight: 600.74. | |
| 1,2,3,4,6-Penta-O-pivaloyl-b-D-galactopyranoside | 1,2,3,4,6-Penta-O-pivaloyl-b-D-galactopyranoside is a carbohydrate synthetic intermediate, chiefly used to research anti-viral and anti-cancer drugs. It shows potential in fighting diseases like HIV and various forms of cancer. CAS No. 108342-85-4. Molecular formula: C31H52O11. Mole weight: 600.74. | |
| 1-(2,3,4,6-Tetrakis-O-benzyl)-2,3-bis(tert-butyldimethylsilyloxy) KRN7000 | 1-(2,3,4,6-Tetrakis-O-benzyl)-2,3-bis(tert-butyldimethylsilyloxy) KRN7000 is a strong agonist for Natural Killer T cells. Mostly utilized to facilitate immunotherapy research, it has been associated with autoimmune diseases and certain cancers. Uses: Intermediate for the preparation of krn7000. Synonyms: N- [ (1S, 2S, 3R) -2, 3-Bis [ [ (1, 1-dimethylethyl) dimethylsilyl] oxy] -1- [ [ [2, 3, 4, 6-tetrakis-O- (phenylmethyl) -α -D-galactopyranosyl] oxy] methyl] heptadecyl] hexacosanamide. CAS No. 205371-69-3. Molecular formula: C90H151NO9Si2. Mole weight: 1447.33. | |
| 1,2:3,4-Di-O-isopropylidene-a-D-galacturonide | 1,2:3,4-Di-O-isopropylidene-a-D-galacturonide is a vital compound in the biomedical industry. It is extensively used for the synthesis of pharmaceutical drugs involved in treating various diseases, especially those related to inflammation and cancer. This compound acts as a key intermediate in the production of potent drugs targeting inflammatory disorders and malignancies. Its versatility and significance make it a valuable tool for drug development and research in the field of biomedicine. Synonyms: 1,2:3,4-Di-O-isopropylidene-a-D-galactopyranuronic acid. CAS No. 25253-46-7. Molecular formula: C12H18O7. Mole weight: 274.27. | |
| 1,2,3,4-Tetra-O-acetyl-6,7-dideoxy-L-galacto-hept-6-enopyranose | 1,2,3,4-Tetra-O-acetyl-6,7-dideoxy-L-galacto-hept-6-enopyranose, an indispensible constituent of the biomedicine sector, assumes a pivotal role in scientific investigation. Manifesting its distinct structural characteristics, this compound finds extensive employment in diverse research and developmental pursuits. Promising prospects have been unveiled concerning its utility for drug design and synthesis, focusing intently on combating multifarious ailments encompassing cancer, diabetes, and viral afflictions. Synonyms: SCHEMBL2614766; 6,7-dideoxy-1,2,3,4-tetraacetate-L-galacto-hept-6-enopyranose; (3S,4R,5R,6S)-6-Vinyltetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate; 1193251-65-8. CAS No. 1193251-65-8. Molecular formula: C15H20O9. Mole weight: 344.31. | |
| 1,2,3,4-Tetra-O-acetyl-6-deoxy-6-fluoro-D-glucopyranose | 1,2,3,4-Tetra-O-acetyl-6-deoxy-6-fluoro-D-glucopyranose, known as a vital intermediate in the realm of biomedical research, exhibits an indispensable importance in the advancement of pioneering therapeutic agents to address diverse pathological conditions. Due to its distinctive and remarkable chemical characteristics, this compound harbors immense potential for deployment in the fabrication of pharmacological entities honing onto designated enzymes or receptors implicated in disease progression pathways, exemplified by cancer or infectious ailments. Synonyms: [4,5,6-triacetyloxy-2-(fluoromethyl)oxan-3-yl] acetate; 31337-78-7; TETRA-O-ACETYL-6-DEOXY-6-FLUORO-D-GLUCOPYRANOSE; AC1LBNVG; DTXSID80337149; FT-0639112. CAS No. 31337-78-7. Molecular formula: C14H19FO9. Mole weight: 350.29. | |
| 1,2,3,4-Tetra-O-acetyl-6-O-(tert-butyldiphenylsilyl)-b-D-galactopyranose | 1,2,3,4-Tetra-O-acetyl-6-O-(tert-butyldiphenylsilyl)-b-D-galactopyranose, a complex carbohydrate employed in glycans synthesis, displays immense possibilities in treating Alzheimer's, cancer, and autoimmune diseases as suggested by recent biomedical research. Its intricate composition and diversified applicability open doors for extensive explorations on complex carbohydrates' therapeutic potential. Molecular formula: C20H34O10Si. Mole weight: 462.56. | |
| 1,2,3,4-Tetra-O-benzoyl-6-O-tert-butyldimethylsilyl-a-D-mannopyranose | 1,2,3,4-Tetra-O-benzoyl-6-O-tert-butyldimethylsilyl-a-D-mannopyranose is a complex and multifaceted carbohydrate reagent that is utilized extensively in the synthesis of diverse glycosyl donors. In addition to its widespread utility in glycosylation reactions, this powerful reagent is also a vital component in the manufacture of a multitude of bioactive compounds, including glycopeptides and glycoproteins, which possess remarkable potential as therapeutics for a diverse range of debilitating diseases, such as cancer and inflammation. The intricate chemical properties of this potent reagent make it an indispensable tool for researchers in the field of medicinal chemistry and biomedical science. Molecular formula: C40H42O10Si. Mole weight: 710.86. | |
| 1,2,3,4-Tetra-O-benzoyl-6-O-tert-butyldimethylsilyl-b-D-galactopyranose | 1,2,3,4-Tetra-O-benzoyl-6-O-tert-butyldimethylsilyl-b-D-galactopyranose, a noteworthy chemical compound, has garnered attention in the realm of oncology for its potential in the development of pioneering drugs to battle prevalent illnesses such as breast and lung cancer. Additionally, it has shown its versatility as a reagent in carbohydrate chemistry, and as a fundamental building block in the synthesis of intricate oligosaccharides. Its significance cannot be underestimated in these domains, providing a crucial foundation for cutting-edge research and breakthrough discoveries. Molecular formula: C40H42O10Si. Mole weight: 710.86. | |
| 1,2,3,4-Tetra-O-benzoyl-6-O-tert-butyldiphenylsilyl-b-D-galactopyranose | 1,2,3,4-Tetra-O-benzoyl-6-O-tert-butyldiphenylsilyl-b-D-galactopyranose is a paramount chemical reagent employed in oligosaccharides' synthesis, extensively adopted in biomedical research to investigate carbohydrates' significance in biological systems, and design advanced therapies and therapeutics for previously untreatable diseases countenancing cancer and infectious diseases - its impact and admissibility towards this domain remains prodigious and prodigiously relevant. Molecular formula: C40H42O10Si. Mole weight: 710.86. | |
| 1,2,3,4-Tetra-O-benzoyl-6-O-triisopropylsilyl-a-D-mannopyranose | 1,2,3,4-Tetra-O-benzoyl-6-O-triisopropylsilyl-a-D-mannopyranose, a glycobiology compound, finds its utility in the synthesis of glycopeptides and glycoconjugates. This versatile molecule presents immense possibilities in the development of therapeutic agents for treating a spectrum of ailments ranging from cancer, bacterial infections to autoimmune diseases. Given its high degree of complexity, this carbohydrate-based entity is believed to offer a challenging yet rewarding avenue for researchers to develop a more comprehensive understanding of its pharmacological potential. Molecular formula: C43H48O10Si. Mole weight: 752.92. | |
| 1,2,3,4-Tetra-O-benzyl-6-O-trityl-b-D-galactopyranose | 1,2,3,4-Tetra-O-benzyl-6-O-trityl-b-D-galactopyranose is a pivotal bridge in the synthesis of carbohydrates, glycosides, and glycoconjugates, assuming a role in the advancement of research on interventions against a myriad of pathologies, encompassing cancer, diabetes, and cardiovascular maladies. Synonyms: 1,2,3,4-Tetra-O-benzyl-6-O-trityl-b-D-galactopyranose; 39687-22-4; (2R,3R,4S,5S,6R)-2,3,4,5-tetrakis(phenylmethoxy)-6-(trityloxymethyl)oxane. CAS No. 39687-22-4. Molecular formula: C53H50O6. Mole weight: 782.96. | |
| 1,2,3,4-Tetra-O-benzyl-6-O-trityl-b-D-glucopyranose | 1,2,3,4-Tetra-O-benzyl-6-O-trityl-b-D-glucopyranose is a compound widely used in the research and development of drugs targeting various diseases, including cancer, diabetes, and Alzheimer's. Its remarkable properties make it a tool for studying carbohydrate chemistry and biological interactions related to glucose metabolism. Synonyms: 1,2,3,4-Tetra-O-benzyl-6-O-trityl-b-D-glucopyranose; 27851-28-1; (2R,3R,4S,5R,6R)-2,3,4,5-tetrakis(phenylmethoxy)-6-(trityloxymethyl)oxane; SCHEMBL990871; GWEFKLSXFOMSCJ-PCUZIXTNSA-N; W-202166; W-202631; (2R,3R,4S,5R,6R)-2,3,4,5-tetrakis(benzyloxy)-6-((trityloxy)methyl)-tetrahydro-2H-pyran; (2R,3R,4S,5R,6R)-2,3,4,5-tetrakis(benzyloxy)-6-((trityloxy)methyl)tetrahydro-2H-pyran. CAS No. 27851-28-1. Molecular formula: C53H50O6. Mole weight: 782.96. | |
| 1,2,3,4-Tetra-O-benzyl-b-D-galactopyranoside | 1,2,3,4-Tetra-O-benzyl-b-D-galactopyranoside is a benzylic glycoside. It is used in the creation of pharmaceutical formulas, specifically serving as an intermediate in the synthesis of various anti-cancer drugs. It is particularly important for research of targeted therapies addressing leukemia and other hematological malignancies. Synonyms: benzyl 2,3,4-tri-O-benzyl-β-D-galactopyranoside; 1,2,3,4-tetra-O-benzyl-D-galactose. CAS No. 35017-04-0. Molecular formula: C34H36O6. Mole weight: 540.65. | |
| 1,2,3,4-Tetra-O-pivaloyl-6-O-(tert-butyldimethylsilyl)-b-D-glucopyranose | 1,2,3,4-Tetra-O-pivaloyl-6-O-(tert-butyldimethylsilyl)-b-D-glucopyranose is a highly significant and pivotal chemical compound extensively utilized in the synthesis of a multitude of therapeutic drugs for tackling the ailments of diabetes and cancer. Its fundamental application lies in the generation of glycosyl donors essential for oligosaccharide synthesis and as a crucial reagent employed in glycosylation reactions. The multifaceted role of this compound in medicinal chemistry makes it an indispensable asset for pharmaceutical research and development. Molecular formula: C32H58O10Si. Mole weight: 630.90. | |
| 1,2,3,4-Tetra-O-pivaloyl-6-O-triisopropylsilyl-b-D-galactopyranose | 1,2,3,4-Tetra-O-pivaloyl-6-O-triisopropylsilyl-b-D-galactopyranose is an indispensable chemical reagent in the synthesis of carbohydrate-based drugs with promising therapeutic potential against cancer and bacterial infections. Its application in the construction of oligosaccharides and glycoconjugates has been well-established, highlighting its crucial role in developing effective treatments against various diseases. An intricate blend of chemical principles underpins the usefulness of this compound, enabling researchers to unravel the complexity of designing novel drugs with enhanced efficacy and safety. Molecular formula: C35H64O10Si. Mole weight: 672.98. | |
| 1,2,3,5,6-Penta-O-acetyl-D-galactofuranose | 1,2,3,5,6-Penta-O-acetyl-D-galactofuranose: An intriguing compound obtained from D-galactose, exhibiting immense potential in the field of biomedical research. Renowned for its acetylated variant, it serves as a fundamental building block in the synthesis of diverse carbohydrate derivatives, holding immense promise for therapeutic interventions. Elucidating its distinctive structural attributes, this compound emerges as a compelling candidate for drug development, specifically targeting afflictions including cancer, bacterial infections, and inflammatory disorders. Synonyms: D-Galactofuranose Pentaacetate; 1,2,3,5,6-PENTA-O-ACETYL-D-GALACTOFURANOSE; [(2R)-2-acetyloxy-2-[(2S,3S,4R)-3,4,5-triacetyloxyoxolan-2-yl]ethyl] acetate; SCHEMBL5696788; (1R)-2-(ACETYLOXY)-1-[(2S,3S,4R)-3,4,5-TRIS(ACETYLOXY)OXOLAN-2-YL]ETHYL ACETATE. CAS No. 62181-82-2. Molecular formula: C16H22O11. Mole weight: 390.4. | |
| 1,2,3,5,6-Penta-O-benzoyl-α,β-galactofuranose | 1,2,3,5,6-Penta-O-benzoyl-α,β-galactofuranose is a synthetic compound commonly used in the biomedical industry. It exhibits potential as a targeted drug delivery system for the treatment of various diseases, including cancer. Through extensive research, this compound has shown promising results in drug development and precision medicine. Synonyms: D-Galactofuranose, pentabenzoate; 138811-45-7. Grades: 98%. CAS No. 138811-45-7. Molecular formula: C41H32O11. Mole weight: 700.69. | |
| 1,2,3,5,6-Penta-O-propanoyl-b-D-glucofuranose | 1,2,3,5,6-Penta-O-propanoyl-b-D-glucofuranose - a versatile chemical hybrid with remarkable potential for gene delivery. Boasting non-toxic and targeted delivery properties, this compound has emerged as a promising option for enhancing drug efficacy in cancer treatments. Be it targeting pesky cancerous cells or expediting biomedical research, the compound's impressive utility cannot be overstated. Molecular formula: C21H32O11. Mole weight: 460.5. | |
| 1,2:3,5-Di-O-isopropylidene-D-glycero-L-gulo-heptitol | Unraveling the multifaceted nature of glycoside mimetics and carbohydrate chemistry, 1,2:3,5-Di-O-isopropylidene-D-glycero-L-gulo-heptitol stands out as a chemical entity of immense significance. Its remarkable potential in the research of diseases such as diabetes and cancer portends a brighter future for the design of efficacious drugs in the coming times. CAS No. 6586-64-7. Molecular formula: C13H24O7. Mole weight: 292.33. | |
| 1-(2,3,5-Tri-O-benzoyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one | 1-(2,3,5-Tri-O-benzoyl-b-D-ribofuranosyl)-5-Nitropyridine-2(1H)-One, a cyclin-dependent kinase 9 (CDK9) inhibitor, has exhibited a compelling potential against malignancies such as breast cancer, prostate cancer and multiple myeloma. It interferes with the propagation and fission of cancer-bearing cells, ultimately restraining the pathogenesis of the malady. This product has shown noteworthy efficacy in the discovery and evolution of progressive anti-tumor therapies whilst facilitating CDK9 inhibition`s related research undertakings. Synonyms: 5-nitro-1-(2',3',5'-tri-O-benzoyl-beta-ribofuranosyl)-2-pyridone; 5-nitro-1-(2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)-2-pyridone; (2R,3R,4R,5R)-2-((Benzoyloxy)methyl)-5-(5-nitro-2-oxopyridin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate; 2(1H)-Pyridinone, 5-nitro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-. Grades: ≥95%. CAS No. 59892-37-4. Molecular formula: C31H24N2O10. Mole weight: 584.53. | |
| 1,2,3,6-Tetra-O-benzyl-4-O-(2,3-di-O-benzyl-4,6-O-benzylidene-a-D-mannopyranosyl)-b-D-glucopyranoside | 1,2,3,6-Tetra-O-benzyl-4-O-(2,3-di-O-benzyl-4,6-O-benzylidene-a-D-mannopyranosyl)-b-D-glucopyranoside is a compound extensively used in the biomedical industry. With its unique chemical structure, it is primarily utilized in the research and development of drugs targeting specific diseases, such as cancer, diabetes, and infectious diseases. Molecular formula: C61H62O11. Mole weight: 971.14. | |
| 1,2,3-Tri-O-acetyl-4,6-O-(4-methoxybenzylidene)-b-D-galactopyranose | 1,2,3-Tri-O-acetyl-4,6-O-(4-methoxybenzylidene)-b-D-galactopyranose is a chemically synthesized derivative of galactose. Its intricate molecular structure presents a high degree of perplexity, making it a useful tool in the study of both benign and malignant cellular processes. As there is considerable variation in the behavior of different cancer types, the compound's burstiness in terms of inhibitory effects must be taken into account when assessing its potential as an anti-cancer agent. Nevertheless, research has shown promising results in suppressing the growth of breast cancer cells, indicating 1,2,3-Tri-O-acetyl-4,6-O-(4-methoxybenzylidene)-b-D-galactopyranose as a compelling entity for future inquiry in cancer treatment. Molecular formula: C20H24O10. Mole weight: 424.4. | |
| 1,2,3-Tri-O-benzoyl-4,6-O-(4-methoxybenzylidene)-b-D-glucopyranose | 1,2,3-Tri-O-benzoyl-4,6-O-(4-methoxybenzylidene)-b-D-glucopyranose, a chemical compound that finds its utility in the biomedical sector, serves as a valuable experimental tool for grounding research on drug delivery. Its properties exhibit promise in the realms of targeted drug delivery, and in mitigating cancers and other afflictions. Molecular formula: C35H30O10. Mole weight: 610.61. | |
| 1,2,3-Tri-O-benzoyl-4,6-O-benzylidene-b-D-galactopyranose | 1,2,3-Tri-O-benzoyl-4,6-O-benzylidene-b-D-galactopyranose is a carbohydrate derivative of high complexity and versatility. Its relevance in the pharmaceutical industry is paramount, serving as a crucial intermediate for the synthesis of a wide array of glycosides and glycoconjugates. This compound has been exploited for the development of HIV-protease inhibitors, as well as for the initiation of anti-tumor and anti-cancer drug research. Its multifaceted nature gives it immense potential for further breakthroughs in the field. Molecular formula: C34H28O9. Mole weight: 580.58. | |
| 1,2,3-Tri-O-benzoyl-4,6-O-benzylidene-b-D-glucopyranose | 1,2,3-Tri-O-benzoyl-4,6-O-benzylidene-b-D-glucopyranose is a key intermediate utilized in the biomedical industry. This compound's unique structure makes it a valuable component in the synthesis of various drugs that treat diseases like cancer, diabetes, and microbial infections. With its versatile applications in drug development, this compound plays a crucial role in advancing biomedical research and improving human health. CAS No. 113544-56-2. Molecular formula: C34H28O9. Mole weight: 580.58. | |
| 1,2,3-Tri-O-benzyl-4,6-O-(4-methoxybenzylidene)-a-D-mannopyranoside | 1,2,3-Tri-O-benzyl-4,6-O-(4-methoxybenzylidene)-a-D-mannopyranoside is a glucoside derivative, possessing a critical role in the research of novel therapeutics specifically designed to combat a spectrum of ailments, such as cancer and infectious diseases. Molecular formula: C35H36O7. Mole weight: 568.66. | |
| 1,2,3-Tri-O-benzyl-4,6-O-(4-methoxybenzylidene)-b-D-glucopyranoside | 1,2,3-Tri-O-benzyl-4,6-O-(4-methoxybenzylidene)-β-D-glucopyranoside, an intriguing and versatile biomedical marvel, unveils unrivaled potential in the realms of therapeutic applications. Its exceptional prowess in combating the perils of an extensive array of cancers, such as breast and colon cancers, stands as a testament to its profound antitumor activity. Within the vast domain of chemical synthesis and medicinal chemistry research, this compound eminently assumes the role of a glycosyl donor, wielding an indomitable influence. CAS No. 95712-22-4. Molecular formula: C35H36O7. Mole weight: 568.66. | |
| 1,2,3-Tri-O-benzyl-4-O-benzoyl-b-D-galactopyranoside | 1,2,3-Tri-O-benzyl-4-O-benzoyl-b-D-galactopyranoside is a highly versatile and indispensable chemical compound that is often employed in drug synthesis and biomedical research. Its utility lies in its remarkable antitumor and anti-inflammatory properties which have been demonstrated in various cutting-edge studies and experiments across the globe. As a result, it has gained immense popularity and has been widely implemented in the development of novel drugs aimed at treating cancer and other complex diseases. Molecular formula: C34H34O7. Mole weight: 554.63. | |
| 1,2,4,5-tetrachloro-3,6-dimethoxybenzene | 1,2,4,5-tetrachloro-3,6-dimethoxybenzene, a chemical compound, possesses great potential in the biomedical field. Its antineoplastic properties indicate that it may be a viable candidate for the development of cancer-fighting drugs. Moreover, it exhibits promise as a herbicide or pesticide. However, comprehensive research is required to unravel its full therapeutic capacity. Synonyms: Tetrachlorohydroquinone dimethyl ether; Benzene, 1,2,4,5-tetrachloro-3,6-dimethoxy-; 1,4-Dimethoxy-2,3,5,6-tetrachlorobenzene; Drosophilin A methyl ether; Tetrachloro-1,4-dimethoxybenzene. Grades: ≥95%. CAS No. 944-78-5. Molecular formula: C8H6Cl4O2. Mole weight: 275.94. | |
| 1,2:4,6-Di-O-isopropylidene-L-sorbofuranose | 1,2:4,6-Di-O-isopropylidene-L-sorbofuranose, a crucial compound in the biomedicine industry, assumes a pivotal role as a versatile synthetic intermediate and building block for the advancement of diverse medications and drugs. Its utility stretches to the synthesis of anti-cancer agents, antivirals, and pharmaceuticals aimed at combating diabetes and cardiovascular ailments, thereby demonstrating its indispensability in biomedical research and drug discovery. CAS No. 62133-03-3. Molecular formula: C12H20O6. Mole weight: 260.28. | |
| 1,2,4,6-Tetra-O-acetyl-3-O-carbamoyl-D-mannopyranose | 1,2,4,6-Tetra-O-acetyl-3-O-carbamoyl-D-mannopyranose, a pivotal compound in the biomedical realm, showcases noteworthy complexity and variations. With origins from mannose, this versatile molecule unveils substantial pharmacological potential within the field of biomedicine. Its indispensability lies in its application for synthesizing and manufacturing diverse drugs that combat ailments such as cancer, diabetes, and microbial infections. Embracing its scientific significance, this vital entity plays a crucial role in advancing biomedical research and innovation. Synonyms: acetic acid (2R,3S,4S,5R,6R)-3,5-diacetoxy-6-acetoxymethyl-4-carbamoyloxytetrahydropyran-2-yl ester; Acetic acid (2R,3S,4S,5R,6R)-2,5-diacetoxy-6-acetoxymethyl-4-carbamoyloxy-tetrahydro-pyran-3-yl ester. Grades: ≥ 95%. CAS No. 99748-11-5. Molecular formula: C15H21NO11. Mole weight: 391.33. | |
| 1,2,4,6-Tetra-O-acetyl-3-O-propargyl-D-glucopyranose | 1,2,4,6-Tetra-O-acetyl-3-O-propargyl-D-glucopyranose, a chemical compound of significant pharmacological relevance, is widely employed in the synthesis of several pharmaceuticals, especially those that exhibit anti-bacterial and anti-cancer activities. Furthermore, its therapeutic potential has also been investigated concerning the treatment of afflictions, namely neurodegenerative maladies, namely Alzheimer's and Parkinson's, showcasing its versatility in medical applications while opening new dimensions of research and development. | |
| 1,2,4,6-Tetra-O-benzyl-b-D-galactopyranoside | 1,2,4,6-Tetra-O-benzyl-b-D-galactopyranoside, a pivotal synthetic glycoprotein and glycan structure reagent, has recently been investigated for its potential involvement as a glycosylation inhibitor. Recognized as a promising agent for a myriad of diseases, ranging from cancer to autoimmune disorders, this chemical is at the forefront of research in the field of medicinal chemistry. | |
| 1,2:5,6-Di-O-isopropylidene-L-chiro-inositol | 1,2:5,6-Di-O-isopropylidene-L-chiro-inositol, a pivotal compound renowned for its therapeutic prowess, occupies a prominent position in the realm of biomedicine. Its pharmacological significance is indisputable, serving as the bedrock for the inception of novel and efficacious drugs aimed at combatting an extensive array of afflictions; most notably, cancer, diabetes, and cardiovascular disorders. In accelerating scientific advancements, this invaluable product assumes a pivotal role, empowering researchers to unravel groundbreaking treatment modalities, fostering hope and resilience in the face of formidable maladies. Synonyms: 2,2,7,7-tetramethylhexahydrobenzo[1,2-d:3,4-d']bis[1,3]dioxole-4,5-diol; L-chiro-Inositol, 1,2:5,6-bis-O-(1-methylethylidene)-; 40617-60-5; D-chiro-Inositol, 1,2:5,6-bis-O-(1-methylethylidene)-; 4,4,11,11-tetramethyl-3,5,10,12-tetraoxatricyclo[7.3.0.0?,?]dodecane-7,8-diol; 4,4,11,11-tetramethyl-3,5,10,12-tetraoxatricyclo[7.3.0.02,6]dodecane-7,8-diol; 1,2:5,6-Di-O-isopropylidene-L-chiro-inositol; NSC133423; SCHEMBL9767712; DTXSID00961026; NSC136028; NSC-133423; NSC-136028; 2,2,7,7-Tetramethylhexahydro-2H,7H-benzo[1,2-d:3,4-d']bis[1,3]dioxole-4,5-diol. CAS No. 65556-81-2. Molecular formula: C12H20O6. Mole weight: 260.28. | |
Our database is helping our users find suppliers everyday.
